Shop

ZULU PLUS TAB
₵8.00
Add to wishlist Add to compareAsk about productDescription
Zulu Plus Tablet is a fixed-dose combination medication containing aceclofenac and paracetamol, used to relieve pain, inflammation, and fever associated with acute conditions such as arthritis, musculoskeletal pain, dental pain, headaches, sprains, and strains. ([scabpharmacy.com](https://www.scabpharmacy.com/product/zulu-plus-tablet/?utm_source=openai))
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that reduces inflammation and pain, while paracetamol (acetaminophen) is an analgesic and antipyretic that alleviates pain and reduces fever. ([scabpharmacy.com](https://www.scabpharmacy.com/product/zulu-plus-tablet/?utm_source=openai))
The typical dosage is one tablet taken twice daily after food to minimize gastric irritation. Each tablet contains 100 mg of aceclofenac and either 325 mg or 500 mg of paracetamol, depending on the specific brand variant. ([scabpharmacy.com](https://www.scabpharmacy.com/product/zulu-plus-tablet/?utm_source=openai))
Common side effects may include nausea, vomiting, abdominal pain, dyspepsia, heartburn, diarrhea, and flatulence. Serious side effects, though rare, can include gastrointestinal bleeding, peptic ulceration, liver toxicity, or elevated liver enzymes, especially with overdose or alcohol consumption. ([scabpharmacy.com](https://www.scabpharmacy.com/product/zulu-plus-tablet/?utm_source=openai))
Patients should inform their healthcare provider of any history of stomach ulcers, gastrointestinal bleeding, liver or kidney disease, and should avoid alcohol during treatment. This medication is not recommended for children unless under physician guidance. If pregnant or breastfeeding, consult a doctor before use. ([scabpharmacy.com](https://www.scabpharmacy.com/product/zulu-plus-tablet/?utm_source=openai))
Zulu Plus Tablet is intended for the symptomatic relief of pain, inflammation, and fever and should be used as directed by a healthcare professional.



Reviews
There are no reviews yet.